发明名称 SUSTAINED-RELEASE ORAL DOSAGE FORMS FOR LOW AQUEOUS SOLUBILITY COMPOUNDS
摘要 Oral dosage forms that contain hydrogel-forming polymers useful for achieving sustained release of API. The formulations disclosed herein may include a hydrogel-forming polymer and a water-insoluble hydrophilic polymer, which acts as a wicking agent to draw water into the formulation. Through that wicking, water combines with the hydrogel-forming polymer to form a hydrogel, thus permitting efficient and sustained release of the API from the hydrogel-forming polymer which may act as a matrix for the API. The formulations disclosed herein are particularly useful for sustained-release of a relatively water-insoluble API, such as tamsulosin, budesonide, and pharmaceutically acceptable salts thereof.
申请公布号 WO2016123482(A3) 申请公布日期 2016.10.06
申请号 WO2016US15647 申请日期 2016.01.29
申请人 MYLAN, INC. 发明人 MURTY, Mummini Aruna;TWIST, John N.;LI, Boyong
分类号 A61K9/20;A61K31/00 主分类号 A61K9/20
代理机构 代理人
主权项
地址